Ludaphar SRL
7.5 FTELudaphar reported total assets of €1.80m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Oct 2026), with 7.5 full-time equivalents.
The score of Ludaphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -3 % Total assets -15 % Headcount (avg FTE) +6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ludaphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Oct 2026
- Year ended 31 Dec 2024filed on 23 Oct 2025
- Year ended 31 Dec 2023filed on 28 Oct 2024
- Year ended 31 Dec 2022filed on 10 Oct 2023
- Year ended 31 Dec 2021filed on 28 Oct 2022
Ludaphar's financial analysis
- Solvency48.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ludaphar
Ludaphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0419.832.529
- VAT number
- BE0419832529
- Peppol
- Registered · 0208:0419832529 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Sep 1979
- Registered office
- 1320 Beauvechain
- Size
- Micro · 7.5 FTE
- Latest accounts
- 2025 · filed on 30 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Ludaphar (SRL) has been based in Beauvechain since 1979, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 12,670 € and equity of 865,939 €; its revenue is not published. With 7.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 48.0%, above the median of its sector (41.5%).
Companies similar to Ludaphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- Nordpharma Retail sale of pharmaceutical products Brussels · balance sheet 810,925 €
- Tornaphar Retail sale of pharmaceutical products Tournai · balance sheet €3.74m
- Apotheek Peeters - Petit Retail sale of pharmaceutical products Maasmechelen · balance sheet €5.05m
- Koltfarma Retail sale of pharmaceutical products Charleroi · balance sheet 488,225 €
- Limafran Retail sale of pharmaceutical products Lincent · balance sheet €2.00m
- EDEHealth Services Business and other management consultancy activities Beyne-Heusay · balance sheet 23,732 €
- M.D.D. Pharma Retail sale of pharmaceutical products Wavre · balance sheet €12.2m
Frequently asked questions about Ludaphar
What is the revenue of Ludaphar?
Ludaphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ludaphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0419832529 for Ludaphar, if the company is VAT-registered. Its company number (CBE) is 0419.832.529.
Where is the registered office of Ludaphar?
According to the CBE register, the registered office of Ludaphar is in 1320 Beauvechain.
What is the equity of Ludaphar?
At the close of the 2025 financial year, the equity of Ludaphar amounts to 865,939 €, a solvency of 48.0% of total assets.
How many people work at Ludaphar?
7.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ludaphar?
The register lists 2 active mandates at Ludaphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ludaphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →